Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 168,700
-14,100 (-7.71%)
Aug 21, 2026, 3:30 PM KST
Sam Chun Dang Pharm. Market Cap
Sam Chun Dang Pharm. has a market cap or net worth of 3.95 trillion as of August 21, 2026. Its market cap has decreased by -4.99% in one year.
Market Cap
3.95T
Enterprise Value
3.98T
Revenue
246.05B
Ranking
n/a
PE Ratio
385.93
Stock Price
168,700.00
ChartMarket Cap Chart
Since September 11, 2001, Sam Chun Dang Pharm.'s market cap has increased from 3.32B to 3.95T, an increase of 118,840.99%. That is a compound annual growth rate of 32.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 3.95T | -26.97% |
| Dec 30, 2025 | 5.41T | 56.57% |
| Dec 30, 2024 | 3.45T | 96.33% |
| Dec 28, 2023 | 1.76T | 82.00% |
| Dec 29, 2022 | 966.58B | 1.04% |
| Dec 30, 2021 | 956.65B | -47.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.78T |
| Celltrion | 44.51T |
| ALTEOGEN | 23.64T |
| Samsung Epis Holdings | 9.41T |
| HLB Co., Ltd. | 5.30T |
| Hanmi Pharm. | 5.06T |
| ABL Bio | 4.62T |
| Peptron | 4.33T |